Comparison Lyell Immunopharma (LYEL) with Competitors
Lyell Immunopharma (LYEL) industry is Biotechnology.
Operating Margin
LYEL-2213050.00%
Industry-2055.25%
Upside-2210994.75%
Free Cash Flow Yield
LYEL-40.41%
Industry-1.75%
Upside-38.66%
P/E
LYEL-1.14
Industry-20.52
Upside+1938.09%
P/S
LYEL11272.00
Industry10.01
Upside+112467.65%
P/B
LYEL1.20
Industry5.15
Upside-76.65%